4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000330
EVP Chief Commercial Officer sold 1,110 shares at an average $359.92 ($399,516)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −120 | $357.31 | $42,878 | 10,973 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −265 | $358.48 | $94,998 | 10,708 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −282 | $359.29 | $101,319 | 10,426 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −123 | $360.62 | $44,356 | 10,303 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −180 | $361.46 | $65,063 | 10,123 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −60 | $362.83 | $21,770 | 10,063 | I |
| DOUBLEDAY RICHARD EVP Chief Commercial Officer | 2020-12-23 | Sale | −80 | $364.15 | $29,132 | 9,983 | I |
| Open-market sales · 1,110 sh · avg $359.92 · $399,516 | |||||||
Loading xslF345X03/edgardoc.xml…